HeartSciences Inc. (HSCS)

HeartSciences Income Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Revenue	0	0.02	0.01	0.01	0.03
Revenue Growth (YoY)	-76.61%	261.17%	-64.17%	-43.86%	-60.11%
Cost of Revenue	0	0.01	0	0.01	0.01
Gross Profit	0	0.01	0	0.01	0.01
Selling, General & Admin	3.97	3.44	3.65	1.71	0.87
Research & Development	4.39	2.88	2.46	3	1.71
Operating Expenses	8.36	6.32	6.12	4.72	2.58
Operating Income	-8.35	-6.31	-6.11	-4.71	-2.57
Interest Expense	-0.5	-0.35	-0.24	-0.37	-0.13
Other Non Operating Income (Expenses)	0.09	0.05	0	0	-0
EBT Excluding Unusual Items	-8.77	-6.61	-6.35	-5.08	-2.7
Gain (Loss) on Sale of Assets	-	-	-	-	0
Other Unusual Items	-	-	-	0.25	0.25
Pretax Income	-8.77	-6.61	-6.35	-4.83	-2.45
Net Income	-8.77	-6.61	-6.35	-4.83	-2.45
Net Income to Common	-8.77	-6.61	-6.35	-4.83	-2.45
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change (YoY)	166.16%	343.39%	139.56%	0.15%	-
EPS (Basic)	-9.34	-18.74	-79.92	-145.48	-74.00
EPS (Diluted)	-9.34	-18.74	-79.92	-145.48	-74.00
Free Cash Flow	-7.42	-6.13	-5.79	-3.65	-2.45
Free Cash Flow Per Share	-7.90	-17.40	-72.85	-109.86	-74.02
Gross Margin	56.78%	67.31%	45.71%	45.11%	58.35%
Operating Margin	-192013.13%	-33901.99%	-118698.33%	-32765.60%	-10030.18%
Profit Margin	-201499.52%	-35511.87%	-123384.27%	-33592.57%	-9577.29%
Free Cash Flow Margin	-170486.23%	-32981.93%	-112463.79%	-25367.54%	-9580.56%
EBITDA	-8.31	-6.28	-6.09	-4.68	-2.53
D&A For EBITDA	0.04	0.03	0.03	0.03	0.03
EBIT	-8.35	-6.31	-6.11	-4.71	-2.57

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q